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This study aims to evaluate the
performance of filaments stored under
different humidities on printing tablets
with the required characteristics.
Six different mixtures of HPC, Soluplus®, magnesium stearate and paracetamol (Table 1) were processed by HME and the filaments stored for 0,
7, 14 and 30 day in desiccators (11, 53, 75 and 93% RH / 24°C). The extrusion was carried out through a die with the temperatures in the barrel set
at 100 (section 1) and (section 2) for all filaments. Printing was carried out at 200°C at a rate of 90mm/s and travelling at 150mm/s for a 100% infill
and a 0.20mm layer thickness. Physical mixtures, filaments and tablets were characterized for thermal behavior by calorimetry (DSC, heating rate
of 10°C/min within the range -10°C and 250°C, for 10-15mg samples placed in aluminum pans), crystallinity, drug content and printability. 10
tablets from each filament were prepared and analyzed.
Table 2: Physical properties of the 3D printed tablets from filaments.
*smaller tablets printed for dose adjustment (n=10)
Table 3: Physical properties of the 3D printed tablets at days 15 and 30 of storage.
CONCLUSIONS
Filaments loaded with paracetamol were
successfully printed delivering tablets with the preset
properties, provided they were used at day 0 (M1-M5)
or throughout 30 day, when stored at 11% RH (M1-
M6).
REFERENCES
1. Pereira GG, Figueiredo S, Fernandes AI, Pinto, JF. Polymer Selection for Hot-Melt Extrusion Coupled to Fused
Deposition Modelling in Pharmaceutics. Pharmaceutics. 2020;12(795).
2. Norman J, Madurawe RD, Moore CMV, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing:
3D-printed drug products. Adv Drug Deliv Rev. 2017;108:39–50.
3. Prasad LK, Smyth H. 3D Printing technologies for drug delivery: a review. Drug Dev Ind Pharm. 2016;42(7):1019–31.
4. Giordano F, Rossi A, Bettini R, Savioli A, Gazzaniga A, Novák C. Thermal behavior of paracetamol-polymeric excipients
mixtures. J Therm Anal Calorim. 2002;68(2):575–90.
Add your logos here
Gabriela G. Pereira1; Ana I. Henriques1; Ana I. Fernandes2; Inês A. Santos2; João F. Pinto1
1 iMed.ULisboa – Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
2 CiiEM, Instituto Universitário Egas Moniz, Quinta da Granja, Monte de Caparica, P-2829-511 Caparica, Portugal
Study of the stability of acetaminophen extrudates for 3D printing 
prepared by hot melt extrusion when stored at different relative humidites
INTRODUCTION
3D printing technology (3DP) offers the
greatest potential to revolutionize the
future of pharmaceutical manufacturing.
Of the many techniques available, fused-
deposition modelling (FDM) (Fig. 1) has
been the most used technique supporting
the potential of the technology to prepare
unit dosage forms 1. Fused deposition
modeling (FDM) (Fig 1) is a technique
based on the deposition of successive
layers of thermoplastic materials after
softening / melting 2. The challenges
related to the use of the technique are
mainly related to the scarcity of adequate
filaments composed of pharmaceutical
grade materials (e.g. polymers with
appropriate characteristics) and
processing related parameters (e.g.
moisture exposure and content) that
besides extrusion, enable printing 3.
Fig. 1-Schematic of a FDM assemblage.
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Table 1: Mixtures (M1-6) made of different 
raw materials (%) considered in the work
HPC Soluplus MgSt Paracetamol
M1 54.0 15.0 1.0 30.0
M2 40.0 9.0 1.0 50.0
M3 54.0 14.0 2.0 30.0
M4 39.5 8.5 2.0 50.0
M5 52.5 12.5 5.0 30.0
M6 37.5 7.5 5.0 50.0
Fig 2: Thermograms from physical mixtures (M1-M6), 
filaments (F1-F6) and 3D-printed tablets (T1-T5). 
Fig 3: Thermograms from paracetamol and 
filaments (F1-F6) storage after 30 day at 11% RH 
At day 0, filaments M1-M5 allowed printing. These filaments had the expected content of paracetamol (98-101%) (Table 2) mostly in an amorphous phase
(Fig.2), by comparison to the initial physical mixture. The fraction of crystallinity found was likely due to partial recrystallization of paracetamol. Tablets did
not show degradation of paracetamol, even though they have undergone a second process of extrusion, as imposed by the technique of printing.
The analysis carried out on days 15 and 30 were performed only on filaments stored at 11%RH, which could be printed. Table 3 presents the data from the
printed tablets which presented a high mass and drug content uniformities between samples. This suggests that moisture is a key factor to allow filaments to
be printed.
Paracetamol present in filaments that were stored at 11%RH remained stable at day 30 of the study, based on the thermal analysis data (Fig. 3). Also, it
was possible to print 10 tablets under the same conditions, as before, from the F1-F6 filaments. Table 3 presents the data for tablet mass and drug content
stressing the need to control filament storage humidity to ensure not only their printability but also the integrity of the drug during the entire storage period.









1 71.78±5.80 99.01±2.25 73.53±5.20 100.02±2.10
2 76.38±1.03 99.80±2.23 78.88±8.14 97.89±2.65
3 83.21±5.27 100.09±1.13 75.97±5.45 99.06±1.09
4 81.31±7.01 101.55±2.20 87.52±5.42 99.59±5.27
5 76.78±3.17 97.08±1.98 77.93±1.11 98.87±1.89









1 65.8±4.8 * 5.91±0.07 2.50±0.022 98.36±2.35
2 87.1±6.1 5.97±0.04 3.00±0.014 97.70±3.01
3 29.5±3.0 * 5.95±0.05 1.50±0.014 104.13±2.14
4 82.1±5.4 5.96±0.04 3.00±0.017 98.15±2.20
5 80.9±4.7 5.98±0.02 3.00±0.029 99.08±0.98
